the booster phenomenon of tuberculin skin testing in patients receiving hemo-dialysis

The Booster Phenomenon of Tuberculin Skin Testing in Patients Receiving Hemo-dialysis

Background: The risk of developing tuberculosis is high among chronic hemodialysis patients. The tuberculin skin test (TST) has been in use for diagnosing latent TB, but few data are available on TST in hemodialysis patients. Objective: This study was done to identify the TST reactivity and frequency of booster effect in serial TST among hemodialysis patients. Methods: A total of 100 patients i...

The booster phenomenon of tuberculin skin testing in patients receiving hemodialysis.

BACKGROUND The risk of developing tuberculosis is high among chronic hemodialysis patients. The tuberculin skin test (TST) has been in use for diagnosing latent TB, but few data are available on TST in hemodialysis patients. OBJECTIVE This study was done to identify the TST reactivity and frequency of booster effect in serial TST among hemodialysis patients. METHODS A total of 100 patients ...

Tuberculin Skin Testing in Children

In 1996, the American Academy of Pediatrics (AAP) recommended targeted tuberculin skin testing (TST) of children while discouraging routine TST of children without risk factors for tuberculosis (TB). Recent studies have provided evidence in support of the targeted TST and recommendations that favor risk assessment over universal screening with TST. While evidence for targeted TB testing exists ...

A retrospective review of the two-step tuberculin skin test in dialysis patients

BACKGROUND Reactivation of latent Mycobacterium tuberculosis infection (LTBI) is a health concern for patients on dialysis or receiving a kidney transplant, as these patients are often immunosuppressed. The most frequently used test for LTBI screening in this population is the tuberculin skin test (TST). The diagnostic accuracy (sensitivity and specificity) of the TST in a contemporary North Am...

Tuberculin skin testing in the era of multidrug-resistant tuberculosis.

Ulcerative tuberculin skin test in a dialysis patient.

Sir, A 53-year-old lady, hypertensive since 2003, was diagnosed with end-stage renal disease (ESRD) in January 2006 and initiated on continuous ambulatory peritoneal dialysis (CAPD). She has been on three exchanges per day with 2.5% dextrose solution. She used to achieve 1.5 L of ultrafiltration per day. Prior to this presentation, she had never suffered any mechanical or metabolic complication...